Business Development is a critical pillar of AbbVie’s future growth, and Global Business Development Forecasting helps determine which external opportunities can create the greatest long-term value. The team brings commercial insight, analytical rigor, and strategic clarity to high-stakes BD decisions by translating science, market dynamics, competitive context, and uncertainty into actionable forecasts.
The Associate Director plays a high-impact and highly visible role in this process, leading forecasts and commercial perspectives that shape executive understanding of opportunity value, risk, and strategic fit. Working across R&D, Commercial, Pipeline Commercial Strategy, CBSO, BD Finance, and other partners, this role sits at the intersection of scientific innovation and commercial strategy and directly supports decisions that influence AbbVie’s future portfolio.
Success requires strong forecasting and commercial analytics expertise, rigorous assumption development, clear executive communication, and the ability to influence across a matrixed organization. Candidates should be curious, collaborative, comfortable with ambiguity, and able to create structure in fast-moving situations. For the right candidate, the role offers meaningful growth through exposure to senior leaders, enterprise-wide relationships, and deeper understanding of both R&D and Commercial strategy.
This role reports to the Director, Global Business Development Forecasting.
Discover exciting opportunities in sports technology. Join innovative companies transforming the sports industry through data, media, and cutting-edge tech.
Salary: $180000-250000
🤖 This salary estimate is calculated by AI based on the job title, location, company, and market data. Use this as a guide for salary expectations or negotiations. The actual salary may vary based on your experience, qualifications, and company policies.
Interested in building your career at AbbVie? Get future opportunities sent straight to your email.
Create AlertDiscover similar positions that might interest you
AbbVie
AbbVie
AbbVie
AbbVie
AbbVie
AbbVie